Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Potbelly Corporation PBPB: This franchise company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.

Potbelly Corporation Price and Consensus

Potbelly Corporation price-consensus-chart | Potbelly Corporation Quote

Concrete Pumping Holdings, Inc. BBCP: This concrete pumping and waste management services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 38.7% over the last 60 days.

CONCRETE PUMPING HOLDINGS, INC. Price and Consensus

CONCRETE PUMPING HOLDINGS, INC. price-consensus-chart | CONCRETE PUMPING HOLDINGS, INC. Quote

Braskem S.A. BAK: This thermoplastic resin company has seen the Zacks Consensus Estimate for its current year earnings increasing 41.9% over the last 60 days.

Braskem S.A. Price and Consensus

Braskem S.A. price-consensus-chart | Braskem S.A. Quote

Novavax, Inc. NVAX: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.

Novavax, Inc. Price and Consensus

Novavax, Inc. price-consensus-chart | Novavax, Inc. Quote

Eton Pharmaceuticals, Inc. ETON: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.

Eton Pharmaceuticals, Inc. Price and Consensus

Eton Pharmaceuticals, Inc. price-consensus-chart | Eton Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Novavax, Inc. (NVAX) : Free Stock Analysis Report

Braskem S.A. (BAK) : Free Stock Analysis Report

Potbelly Corporation (PBPB) : Free Stock Analysis Report

Eton Pharmaceuticals, Inc. (ETON) : Free Stock Analysis Report

CONCRETE PUMPING HOLDINGS, INC. (BBCP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research